Literature DB >> 6325495

Estimation of rotavirus immunoglobulin G antibodies in human serum samples by enzyme-linked immunosorbent assay: expression of results as units derived from a standard curve.

R F Bishop, E Cipriani, J S Lund, G L Barnes, C S Hosking.   

Abstract

A method for estimating rotavirus immunoglobulin G (IgG) antibodies by assay of human serum samples at a single serum dilution was studied. Antibody was measured by enzyme-linked immunosorbent assay (ELISA). The optical density of the reaction with a 1:100 dilution of each serum was expressed as ELISA units of antirotavirus IgG by reference to a standard curve. This standard curve was obtained by incorporation in each assay of five dilutions of a serum containing an arbitrary number of units of antirotavirus IgG. Test serum samples found to contain high amounts of antirotavirus IgG were reassayed at a 1:1,000 dilution. There was good correlation between antirotavirus IgG ELISA units in 45 serum samples and endpoint titers of the same samples (Spearman rank correlation coefficient rs, 0.95). Seroconversion during rotavirus infection was defined as an increase in antirotavirus IgG ELISA units per milliliter of greater than 28% (2 X intra-run coefficient of variation of the assay) in consecutive serum samples from the same child. Paired serum samples from nine children with diarrhea not due to rotavirus infection showed no seroconversions. Paired samples from eight children with rotavirus infection showed seroconversions. Estimation of antirotavirus IgG ELISA units in serum is simple, rapid, reproducible, and economical of serum samples. Standardization of results could be achieved by worldwide distribution of a standard serum. Its use would facilitate epidemiological surveys to evaluate potential rotavirus vaccines.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325495      PMCID: PMC271092          DOI: 10.1128/jcm.19.4.447-452.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Comparison of an enzyme-linked immunosorbent assay for quantitation of rotavirus antibodies with complement fixation in an epidemiological survey.

Authors:  L H Ghose; R D Schnagl; I H Holmes
Journal:  J Clin Microbiol       Date:  1978-09       Impact factor: 5.948

2.  Quantitative, semiautomated, enzyme-linked immunosorbent assay for viral antibodies.

Authors:  P O Leinikki; S Passila
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

3.  Evaluation of some of the parameters of the enzyme-linked immunospecific assay.

Authors:  S L Bullock; K W Walls
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

4.  The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity.

Authors:  J E Butler; T L Feldbush; P L McGivern; N Stewart
Journal:  Immunochemistry       Date:  1978-02

5.  Relation between viruses from acute gastroenteritis of children and newborn calves.

Authors:  T H Flewett; A S Bryden; H Davies; G N Woode; J C Bridger; J M Derrick
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

6.  Complement-fixing antibody response to rotavirus infection.

Authors:  I D Gust; R C Pringle; G L Barnes; G P Davidson; R F Bishop
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

7.  Rotavirus infection in adults. Results of a prospective family study.

Authors:  W M Wenman; D Hinde; S Feltham; M Gurwith
Journal:  N Engl J Med       Date:  1979-08-09       Impact factor: 91.245

8.  New complement-fixation test for the human reovirus-like agent of infantile gastroenteritis. Nebraska calf diarrhea virus used as antigen.

Authors:  A Z Kapikian; W L Cline; C A Mebus; R G Wyatt; A R Kalica; H D James; D VanKirk; R M Chanock
Journal:  Lancet       Date:  1975-05-10       Impact factor: 79.321

9.  Immunological response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbent assay.

Authors:  R H Yolken; R G Wyatt; H W Kim; A Z Kapikian; R M Chanock
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests.

Authors:  A Z Kapikian; H W Kim; R G Wyatt; W J Rodriguez; S Ross; W L Cline; R H Parrott; R M Chanock
Journal:  Science       Date:  1974-09-20       Impact factor: 47.728

View more
  12 in total

1.  Enzyme-linked immunosorbent assays for measurement of reovirus immunoglobulin G, A, and M levels in serum.

Authors:  S C Richardson; R F Bishop; A L Smith
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

2.  Seroepidemiology of cryptosporidiosis in children in Papua New Guinea and Australia.

Authors:  V J Groves; D Lehmann; G L Gilbert
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

3.  Levels of serum immunoglobulin G specific to bacterial surface protein A of Tannerella forsythia are related to periodontal status.

Authors:  Lindsay M Hall; Robert G Dunford; Robert J Genco; Ashu Sharma
Journal:  J Periodontol       Date:  2011-05-24       Impact factor: 6.993

4.  Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus.

Authors:  B J Zheng; S X Han; Y K Yan; X R Liang; G Z Ma; Y Yang; M H Ng
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

5.  Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood.

Authors:  B S Coulson; K Grimwood; P J Masendycz; J S Lund; N Mermelstein; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

6.  Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.

Authors:  A C Linhares; Y B Gabbay; J D Mascarenhas; R B de Freitas; C S Oliveira; N Bellesi; T A Monteiro; Z Lins-Lainson; F L Ramos; S A Valente
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

7.  Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.

Authors:  Mee-Yew Chen; Carl D Kirkwood; Julie Bines; Daniel Cowley; Daniel Pavlic; Katherine J Lee; Francesca Orsini; Emma Watts; Graeme Barnes; Margaret Danchin
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

8.  Prospective study of community-acquired rotavirus infection.

Authors:  B J Zheng; S K Lo; J S Tam; M Lo; C Y Yeung; M H Ng
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

9.  Optimizing selection of large animals for antibody production by screening immune response to standard vaccines.

Authors:  Mary K Thompson; Peter C Fridy; Sarah Keegan; Brian T Chait; David Fenyö; Michael P Rout
Journal:  J Immunol Methods       Date:  2016-01-09       Impact factor: 2.303

10.  Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

Authors:  K Grimwood; J C Lund; B S Coulson; I L Hudson; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.